Setterwalls has assisted Keensight Capital with an investment in Bentley Endovascular Group AB

Setterwalls has assisted Keensight Capital in connection with the acquisition of a minority stake in the medical technology holding company Bentley Endovascular Group AB. Keensight Capital will, along with the co-investors A.P. Moller Holding and Bonit Capital, support the company’s go-to-market strategy for the US market and the preparation for an IPO.

Keensight Capital is one of the leading European Growth Buyout firms, committed to supporting entrepreneurs as they implement their growth strategies. For over 20 years, Keensight Capital’s team of seasoned professionals has leveraged their knowledge of investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €10 million to €400 million.

Bentley Endovascular Group AB, headquartered in Stockholm, is a holding company with the subsidiaries Bentley InnoMed GmbH in Germany and Qmedics AG in Switzerland. Bentley InnoMed GmbH develops, manufactures, and markets implants and catheters for the endovascular treatment of peripheral vascular and aortic disease. The company ranks among the world-leading manufacturers within its respective product areas. Qmedics AG specializes in dilatation balloons and acts as a key supplier of essential components for Bentley InnoMed GmbH.